Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN)
(2012)
JAMA 307: 1717-26
MeSH Terms: Angina Pectoris, Bone Marrow Transplantation, Coronary Artery Disease, Coronary Circulation, Double-Blind Method, Female, Heart Failure, Humans, Injections, Male, Middle Aged, Myocardial Ischemia, Oxygen Consumption, Tomography, Emission-Computed, Single-Photon, Transplantation, Autologous, Treatment Outcome, Ventricular Dysfunction, LeftAdded November 13, 2012